NCT04276935View on ClinicalTrials.gov

Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions

High Grade Anal Canal Squamous Intraepithelial NeoplasiaHuman Immunodeficiency Virus

Interventions

OTHER

Interview

Participate in cognitive interview

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (4)

33136

Jackson Memorial Hospital, Miami

60614

Anal Dysplasia Clinic MidWest, Chicago

94143

University of California - San Francisco, San Francisco

98101

Virginia Mason Medical Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

The Emmes Company, LLC

INDUSTRY

lead

AIDS Malignancy Consortium

NETWORK

NCT04276935 - Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions | Biotech Hunter | Biotech Hunter